Log in

NASDAQ:PRTKParatek Pharmaceuticals News Headlines

$5.37
-0.15 (-2.72 %)
(As of 07/9/2020 04:00 PM ET)
Add
Compare
Today's Range
$5.12
Now: $5.37
$5.60
50-Day Range
$4.22
MA: $4.75
$5.52
52-Week Range
$2.50
Now: $5.37
$5.89
Volume412,300 shs
Average Volume753,350 shs
Market Capitalization$231.62 million
P/E RatioN/A
Dividend YieldN/A
Beta1.53

Headlines

Paratek Pharmaceuticals (NASDAQ PRTK) News Headlines

Source:
DateHeadline
 Brokerages Anticipate Paratek Pharmaceuticals Inc (NASDAQ:PRTK) Will Announce Earnings of $0.02 Per Share Brokerages Anticipate Paratek Pharmaceuticals Inc (NASDAQ:PRTK) Will Announce Earnings of $0.02 Per Share
www.americanbankingnews.com - July 9 at 5:40 PM
FY2024 EPS Estimates for Paratek Pharmaceuticals Inc Lowered by G.Research (NASDAQ:PRTK)FY2024 EPS Estimates for Paratek Pharmaceuticals Inc Lowered by G.Research (NASDAQ:PRTK)
www.americanbankingnews.com - June 29 at 2:18 AM
Paratek Pharmaceuticals Inc (NASDAQ:PRTK) Receives Average Rating of "Buy" from BrokeragesParatek Pharmaceuticals Inc (NASDAQ:PRTK) Receives Average Rating of "Buy" from Brokerages
www.americanbankingnews.com - June 26 at 3:29 AM
Paratek Pharmaceuticals Inc (NASDAQ:PRTK) Expected to Post Quarterly Sales of $45.21 MillionParatek Pharmaceuticals Inc (NASDAQ:PRTK) Expected to Post Quarterly Sales of $45.21 Million
www.americanbankingnews.com - June 19 at 4:08 AM
 Analysts Anticipate Paratek Pharmaceuticals Inc (NASDAQ:PRTK) to Announce $0.02 Earnings Per Share Analysts Anticipate Paratek Pharmaceuticals Inc (NASDAQ:PRTK) to Announce $0.02 Earnings Per Share
www.americanbankingnews.com - June 17 at 3:26 PM
Edited Transcript of PRTK earnings conference call or presentation 11-May-20 12:30pm GMTEdited Transcript of PRTK earnings conference call or presentation 11-May-20 12:30pm GMT
finance.yahoo.com - June 5 at 10:55 PM
Paratek Pharmaceuticals Announces Change to Time of 2020 Annual Meeting of StockholdersParatek Pharmaceuticals Announces Change to Time of 2020 Annual Meeting of Stockholders
finance.yahoo.com - May 29 at 12:42 PM
Paratek Pharmaceuticals to Present at Jefferies 2020 Virtual Healthcare ConferenceParatek Pharmaceuticals to Present at Jefferies 2020 Virtual Healthcare Conference
finance.yahoo.com - May 28 at 11:34 AM
Paratek Plods AlongParatek Plods Along
seekingalpha.com - May 14 at 12:22 AM
Paratek Pharmaceuticals, Inc. (PRTK)Paratek Pharmaceuticals, Inc. (PRTK)
uk.finance.yahoo.com - May 11 at 9:00 PM
Paratek Pharmaceuticals, Inc. 2020 Q1 - Results - Earnings Call PresentationParatek Pharmaceuticals, Inc. 2020 Q1 - Results - Earnings Call Presentation
seekingalpha.com - May 11 at 9:00 PM
Paratek Pharmaceuticals to Present at Bank of America Securities 2020 Health Care ConferenceParatek Pharmaceuticals to Present at Bank of America Securities 2020 Health Care Conference
finance.yahoo.com - May 11 at 9:00 PM
Paratek Pharmaceuticals, Inc. (PRTK) CEO Evan Loh on Q1 2020 Results - Earnings Call TranscriptParatek Pharmaceuticals, Inc. (PRTK) CEO Evan Loh on Q1 2020 Results - Earnings Call Transcript
seekingalpha.com - May 11 at 3:59 PM
Paratek Pharmaceuticals: Q1 Earnings InsightsParatek Pharmaceuticals: Q1 Earnings Insights
www.benzinga.com - May 11 at 8:53 AM
Paratek Pharmaceuticals to Report First Quarter 2020 Financial Results on May 11, 2020Paratek Pharmaceuticals to Report First Quarter 2020 Financial Results on May 11, 2020
finance.yahoo.com - April 30 at 6:28 PM
Will Paratek Pharmaceuticals Continue to Surge Higher?Will Paratek Pharmaceuticals Continue to Surge Higher?
finance.yahoo.com - April 28 at 4:35 PM
Seth Klarman Dials Down Akebia Therapeutics StakeSeth Klarman Dials Down Akebia Therapeutics Stake
finance.yahoo.com - April 14 at 12:43 PM
BARDA initiates funding for post-marketing studies of Paratek Pharmas NuzyraBARDA initiates funding for post-marketing studies of Paratek Pharma's Nuzyra
seekingalpha.com - April 2 at 5:38 PM
Paratek Pharmaceuticals Announces Initiation of Funding from BARDA for All FDA Required Post-marketing Studies for NUZYRA• (omadacycline)Paratek Pharmaceuticals Announces Initiation of Funding from BARDA for All FDA Required Post-marketing Studies for NUZYRA• (omadacycline)
finance.yahoo.com - April 2 at 5:38 PM
BARRDA initiates funding for Paratek Pharmas NuzyraBARRDA initiates funding for Paratek Pharma's Nuzyra
seekingalpha.com - April 1 at 5:42 PM
BARDA initiates funding for Paratek Pharmas NuzyraBARDA initiates funding for Paratek Pharma's Nuzyra
seekingalpha.com - April 1 at 5:42 PM
Paratek Pharmaceuticals Announces Initiation of Funding from BARDA for Security Requirements and U.S. Onshoring of the Manufacturing Supply Chain for NUZYRA• (omadacycline)Paratek Pharmaceuticals Announces Initiation of Funding from BARDA for Security Requirements and U.S. Onshoring of the Manufacturing Supply Chain for NUZYRA• (omadacycline)
finance.yahoo.com - April 1 at 5:42 PM
Paratek Pharmaceuticals, Inc. Just Reported Full-Year Earnings: Have Analysts Changed Their Mind On The Stock?Paratek Pharmaceuticals, Inc. Just Reported Full-Year Earnings: Have Analysts Changed Their Mind On The Stock?
finance.yahoo.com - March 14 at 3:08 PM
BARDA files for emergency use of Paratek Pharmas Nuzyra for anthraxBARDA files for emergency use of Paratek Pharma's Nuzyra for anthrax
seekingalpha.com - March 10 at 7:14 PM
Paratek Pharmaceuticals Announces the Submission of the pre-Emergency Use Authorization Application to the FDA for NUZYRA• (omadacycline)Paratek Pharmaceuticals Announces the Submission of the pre-Emergency Use Authorization Application to the FDA for NUZYRA• (omadacycline)
www.globenewswire.com - March 10 at 7:14 PM
Edited Transcript of PRTK earnings conference call or presentation 25-Feb-20 9:30pm GMTEdited Transcript of PRTK earnings conference call or presentation 25-Feb-20 9:30pm GMT
finance.yahoo.com - March 7 at 2:00 PM
Paratek Announces Inducement Grants under NASDAQ Listing Rule 5635(c)(4)Paratek Announces Inducement Grants under NASDAQ Listing Rule 5635(c)(4)
finance.yahoo.com - March 2 at 5:08 PM
Paratek Pharmaceuticals: A Bright 2020 AheadParatek Pharmaceuticals: A Bright 2020 Ahead
seekingalpha.com - February 28 at 7:24 AM
Paratek Pharmaceuticals, Inc. Just Reported Yearly Earnings And Analysts Are Lifting Their EstimatesParatek Pharmaceuticals, Inc. Just Reported Yearly Earnings And Analysts Are Lifting Their Estimates
finance.yahoo.com - February 27 at 2:58 PM
Paratek Pharmaceuticals to Present at the SVB Leerink 9th Annual Global Healthcare ConferenceParatek Pharmaceuticals to Present at the SVB Leerink 9th Annual Global Healthcare Conference
finance.yahoo.com - February 26 at 12:23 PM
Paratek Pharmaceuticals Announces Full Year 2019 Total Revenues of $16.5 Million including NUZYRA® (omadacycline) Net Sales of $11.5 MillionParatek Pharmaceuticals Announces Full Year 2019 Total Revenues of $16.5 Million including NUZYRA® (omadacycline) Net Sales of $11.5 Million
finance.yahoo.com - February 25 at 7:53 PM
Paratek Pharmaceuticals (PRTK) Reports Q4 Loss, Tops Revenue EstimatesParatek Pharmaceuticals (PRTK) Reports Q4 Loss, Tops Revenue Estimates
finance.yahoo.com - February 25 at 7:53 PM
Paratek Announces License Grant to Almirall for SEYSARA® (sarecycline) for Greater China RegionParatek Announces License Grant to Almirall for SEYSARA® (sarecycline) for Greater China Region
finance.yahoo.com - February 24 at 8:08 AM
Paratek Pharmaceuticals, Inc. Common Stock (PRTK) Institutional HoldingsParatek Pharmaceuticals, Inc. Common Stock (PRTK) Institutional Holdings
www.nasdaq.com - February 23 at 11:41 PM
Is Paratek Pharmaceuticals, Inc. (NASDAQ:PRTK) A Volatile Stock?Is Paratek Pharmaceuticals, Inc. (NASDAQ:PRTK) A Volatile Stock?
finance.yahoo.com - February 17 at 5:42 PM
Paratek Pharmaceuticals to Report Fourth Quarter and Full Year 2019 Financial Results on February 25, 2020Paratek Pharmaceuticals to Report Fourth Quarter and Full Year 2019 Financial Results on February 25, 2020
finance.yahoo.com - February 13 at 6:04 PM
Paratek Pharmaceuticals: Setbacks And SuccessesParatek Pharmaceuticals: Setbacks And Successes
seekingalpha.com - January 2 at 4:01 PM
Are Options Traders Betting on a Big Move in Paratek Pharmaceuticals (PRTK) Stock?Are Options Traders Betting on a Big Move in Paratek Pharmaceuticals (PRTK) Stock?
finance.yahoo.com - December 20 at 2:03 PM
Why this King of Prussia biopharmas stock rose 32% ThursdayWhy this King of Prussia biopharma's stock rose 32% Thursday
www.bizjournals.com - December 19 at 10:58 PM
Why this King of Prussia biopharma's stock rose 32% ThursdayWhy this King of Prussia biopharma's stock rose 32% Thursday
finance.yahoo.com - December 19 at 10:58 PM
Why One Analyst Still Sees Almost 200% Upside in Paratek Pharma, Even After Its Huge GainWhy One Analyst Still Sees Almost 200% Upside in Paratek Pharma, Even After Its Huge Gain
247wallst.com - December 19 at 5:58 PM
Notable Thursday Option Activity: PRTK, VIAC, MSFTNotable Thursday Option Activity: PRTK, VIAC, MSFT
www.nasdaq.com - December 19 at 5:58 PM
CAG, RAD among premarket gainersCAG, RAD among premarket gainers
seekingalpha.com - December 19 at 12:57 PM
BioShield/Anthrax Contract Sets Solid Stage for Paratek Pharmaceuticals in 2020BioShield/Anthrax Contract Sets Solid Stage for Paratek Pharmaceuticals in 2020
www.msn.com - December 19 at 12:57 PM
Parateks stock rockets on government contractParatek's stock rockets on government contract
www.marketwatch.com - December 19 at 12:57 PM
Paratek's stock rockets on government contractParatek's stock rockets on government contract
finance.yahoo.com - December 19 at 12:57 PM
Paratek nabs BARDA contract for Nuzyra; shares up 53% premarketParatek nabs BARDA contract for Nuzyra; shares up 53% premarket
seekingalpha.com - December 19 at 7:56 AM
Paratek Awarded BARDA Project BioShield Contract for NUZYRA®Paratek Awarded BARDA Project BioShield Contract for NUZYRA®
finance.yahoo.com - December 18 at 6:55 PM
Is Paratek Pharmaceuticals Inc (PRTK) Going to Burn These Hedge Funds?Is Paratek Pharmaceuticals Inc (PRTK) Going to Burn These Hedge Funds?
finance.yahoo.com - December 13 at 7:07 PM
Seth Klarman Pares Paratek Pharmaceuticals StakeSeth Klarman Pares Paratek Pharmaceuticals Stake
finance.yahoo.com - December 10 at 1:41 PM
This page was last updated on 7/10/2020 by MarketBeat.com Staff

30 Days of MarketBeat All Access for $1.00

Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools:

  • Best-in-Class Portfolio Monitoring

    View the latest news, buy/sell ratings, SEC filings and insider transactions for your stocks. Compare your portfolio performance to leading indices and get personalized stock ideas based on your portfolio.

  • Stock Ideas and Recommendations

    Get daily stock ideas top-performing Wall Street analysts. Get short term trading ideas from the MarketBeat Idea Engine. View which stocks are hot on social media with MarketBeat's trending stocks report.

  • Advanced Stock Screeners and Research Tools

    Identify stocks that meet your criteria using seven unique stock screeners. See what's happening in the market right now with MarketBeat's real-time news feed. Export data to Excel for your own analysis.

Start Your Risk-Free Trial Subscription Here

Enter your email address below to receive a concise daily summary of analysts' upgrades, downgrades and new coverage with MarketBeat.com's FREE daily email newsletter.